Kari Grønås
Directeur/Membre du Conseil chez SPAGO NANOMEDICAL AB
Fortune : 4 185 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Audun Tornes | M | - | - | |
| Mats Hansen | M | 53 | 9 ans | |
| Hans Vassgård Eid | M | 57 | - | |
| Gudrun Trøite | M | - | - | |
| Oskar Axelsson | M | 62 | 17 ans | |
| Nicklas Westerholm | M | 48 | 5 ans | |
| Rune Skeie | M | 51 | 6 ans | |
| Anne Hovi Worsøe | F | 60 | 3 ans | |
| Jonas Hallén | M | - |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 5 ans |
| Jörg Klingelhöfer | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 6 ans |
| Carlos de Sousa | M | 66 | 4 ans | |
| Tove Sivik Sonne | F | 44 | 11 ans | |
| Paul Hargreaves | M | 55 | 3 ans | |
| Ingunn Hagen Westgaard | F | - | - | |
| Mc Callion Orla | M | - | 3 ans | |
| Haakon Stenrod | M | 44 | 4 ans | |
| Birgitte Gangmark Villmo | F | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Jens Bjørheim | M | - | - | |
| Hanna Olsson | F | 44 | 5 ans | |
| Debra Stephanie Barker | M | 61 | 5 ans | |
| Kjetil Hestdal | M | 64 |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services K & K AS manages securities. The company was founded on June 26, 2002 and is headquartered in Oslo, Norway. | 22 ans |
| Susanne Stuffers | M | 43 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Antonius Berkien | M | 56 | 4 ans | |
| Øyvind Eriksen | M | 60 |
Norwegian Cancer Society
| - |
| Gustav Gaudernack | M | - | - | |
| Øivind Foss | M | - | - | |
| Christian Schweiger | M | 57 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 4 ans |
| Henrik Schüssler | M | 61 | 9 ans | |
| Alan Henry Raffensperger | M | 64 | 1 ans | |
| Yuri Khodjamirian | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Jónas Einarsson | M | 67 | 13 ans | |
| Hans Arwidsson | M | 66 | 1 ans | |
| Øystein Soug | M | 55 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 2 ans |
| Farzad Abdi-Dezfuli | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Hilde Furberg | F | 65 | 4 ans | |
| Susan Foden | M | 71 | 8 ans | |
| Stein Holst Annexstad | M | 80 | 3 ans | |
| James Barnes | M | - | 4 ans | |
| Petter Nielsen | M | - | 3 ans | |
| Sten Nilsson | M | 76 | 10 ans | |
| Murray Yule | M | - | 7 ans | |
| Peter Leander | M | 67 | 11 ans | |
| Øyvind Kongstun Arnesen | M | 67 | - | |
| Debbie Molyneux | F | - | 4 ans | |
| Eva S. Dugstad | F | - | - | |
| Dominic Smethurst | M | 50 | - | |
| Tone Bjaaland | M | - | - | |
| Grunde Eriksen | M | - | - | |
| Kristin Louise A. Wilhelmsen | F | 62 | 4 ans | |
| Eugen Steiner | M | 70 | 4 ans | |
| Mikael Lönn | M | 75 | - | |
| Bengt Håkan Englund | M | 72 | 3 ans | |
| Aitana Peire | M | - | 3 ans | |
| Anthony Brown | M | - | 4 ans | |
| Alan Barge | M | - | 1 ans | |
| Pamela A. Trail | M | 68 | - | |
| Jon-Øyvind Eriksen | M | 60 | 7 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Norvège | 45 | 78,95% |
| Suède | 12 | 21,05% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Kari Grønås
- Réseau Personnel
